Related Experiment Videos
Management of bowel dysfunction in people with multiple sclerosis
1King's College, London.
British Journal of Community Nursing
|October 19, 2006
Summary
Bowel dysfunction significantly affects individuals with multiple sclerosis (MS), impacting physical and mental health. Evidence supports thorough assessment, fluid/fiber intake, and pelvic floor exercises for managing MS-related bowel issues.
Area of Science:
- Neurology
- Gastroenterology
- Rehabilitation Science
Background:
- Bowel dysfunction is a prevalent and impactful issue for individuals with multiple sclerosis (MS).
- It significantly affects physical functioning and psychosocial wellbeing in the MS population.
- Current understanding of best practices for managing MS-related bowel dysfunction is based on limited evidence.
Purpose of the Study:
- To review the existing evidence for best practices in managing bowel dysfunction in people with multiple sclerosis (MS).
- To identify effective interventions and highlight areas where evidence is limited.
Main Methods:
- A comprehensive review of the limited available scientific literature.
- Analysis of evidence related to bowel assessment, fluid and fiber intake, pelvic floor exercises, biofeedback, aerobic exercise, anal plugs, and pharmacological interventions.
Main Results:
- Thorough bowel assessment is crucial for effective management.
- Adequate fluid and fiber intake, alongside pelvic floor exercises, demonstrates clear benefits.
- Biofeedback therapy, aerobic exercise, and anal plugs offer potential benefits for select individuals.
- Pharmacological interventions require careful consideration due to potential risks and limited evidence.
Conclusions:
- A multi-faceted approach combining assessment, lifestyle modifications, and targeted therapies is recommended for MS-related bowel dysfunction.
- Further research is needed to strengthen the evidence base for various interventions.
- Individualized treatment plans are essential, considering the diverse impact of MS on bowel function.
Related Concept Videos
Irritable Bowel Syndrome III: Medical and Nursing Management
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...